loading

Regencell Bioscience Holdings Ltd Azioni (RGC) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
$22.08
price down icon 1.82%
drug_manufacturers_specialty_generic RDY
$13.93
price up icon 0.14%
$11.70
price up icon 2.09%
$141.70
price down icon 4.73%
$510.94
price up icon 2.19%
Capitalizzazione:     |  Volume (24 ore):